BIOMAT Database Logo BIOMAT Database Logo

Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. 1996

L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital National Health Service Trust, Manchester, United Kingdom.

Allogeneic bone marrow transplantation is the most effective treatment for Hurler syndrome but, since this therapy is not available to all patients, we have considered an alternative approach based on transfer and expression of the normal gene in autologous bone marrow. A retroviral vector carrying the full-length cDNA for alpha-L-iduronidase has been constructed and used to transduce bone marrow from patients with this disorder. Various gene-transfer protocols have been assessed including the effect of intensive schedules of exposure of bone marrow to viral supernatant and the influence of growth factors. With these protocols, we have demonstrated successful gene transfer into primitive CD34+ cells and subsequent enzyme expression in their maturing progeny. Also, by using long-term bone marrow cultures, we have demonstrated high levels of enzyme expression sustained for several months. The efficiency of gene transfer has been assessed by PCR analysis of hemopoietic colonies as 25-56%. No advantage has been demonstrated for the addition of growth factors or intensive viral exposure schedules. The enzyme is secreted into the medium and functional localization has been demonstrated by reversal of the phenotypic effects of lysosomal storage in macrophages. This work suggests that retroviral gene transfer into human bone marrow may offer the prospect for gene therapy of Hurler syndrome in young patients without a matched sibling donor.

UI MeSH Term Description Entries
D007068 Iduronidase An enzyme that hydrolyzes iduronosidic linkages in desulfated dermatan. Deficiency of this enzyme produces Hurler's syndrome. EC 3.2.1.76. alpha-L-Idosiduronase,alpha-L-Iduronidase,alpha L Idosiduronase,alpha L Iduronidase
D008059 Mucopolysaccharidosis I Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing. Hurler's Syndrome,Hurler-Scheie Syndrome,Lipochondrodystrophy,Mucopolysaccharidosis V,Pfaundler-Hurler Syndrome,Scheie's Syndrome,Gargoylism,Gargoylism, Hurler Syndrome,Hurler Disease,Hurler Syndrome,Hurler's Disease,Mucopolysaccharidosis 1,Mucopolysaccharidosis 5,Mucopolysaccharidosis I-S,Mucopolysaccharidosis Type I,Mucopolysaccharidosis Type Ih,Mucopolysaccharidosis Type Ih S,Mucopolysaccharidosis Type Is,Scheie Syndrome,alpha-L-Iduronidase Deficiency,Disease, Hurler's,Gargoylisms,Hurler Scheie Syndrome,Hurler Syndrome Gargoylism,Lipochondrodystrophies,Mucopolysaccharidosis I S,Mucopolysaccharidosis Is,Mucopolysaccharidosis Type Ihs,Syndrome, Hurler's,Syndrome, Scheie's,Type Ih, Mucopolysaccharidosis,Type Ihs, Mucopolysaccharidosis,alpha L Iduronidase Deficiency,alpha-L-Iduronidase Deficiencies
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
Atypical Hurler syndrome without alpha-L-iduronidase deficiency.
October 1976, The Tohoku journal of experimental medicine,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
Orofacial features of Scheie (Hurler-Scheie) syndrome (alpha-L-iduronidase deficiency).
July 1990, Oral surgery, oral medicine, and oral pathology,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
[Alpha-L-iduronidase activity in fibroblasts of patients with Hurler syndrome].
January 1975, Acta biologica et medica Germanica,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
Long-term outcome of Hurler syndrome following bone marrow transplantation.
April 1993, American journal of medical genetics,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
Hurler syndrome: a patient with abnormally high levels of alpha-L-iduronidase protein.
June 1992, Biochemical medicine and metabolic biology,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
The relationship of alpha-L-iduronidase and Hurler corrective factor.
January 1976, Archives of biochemistry and biophysics,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
Hurler syndrome: alpha-L-iduronidase activity in leukocytes as a method for heterozygote detection.
June 1976, Pediatric research,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings.
November 1976, Neurology,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
alpha-L-iduronidase activity in leukocytes: diagnosis of homozygotes and heterozygotes of the Hurler syndrome.
May 1976, European journal of pediatrics,
L J Fairbairn, and L S Lashford, and E Spooncer, and R H McDermott, and G Lebens, and J E Arrand, and J R Arrand, and I Bellantuono, and R Holt, and C E Hatton, and A Cooper, and G T Besley, and J E Wraith, and D S Anson, and J J Hopwood, and T M Dexter
A canine model of human alpha-L-iduronidase deficiency.
October 1983, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!